Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

CPD Modern medicines series SGLT2 Inhibitors: Webinar 3 - SGLT2 inhibitors and the kidney

Modern medicines series SGLT2 Inhibitors: Webinar 3 - SGLT2 inhibitors and the kidney

Publication date: Wednesday, 10 March 2021
Contributor(s): Cliff Bailey, Pam Brown

Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease, specifically: Kidney disease in type 2 diabetes; SGLT2 inhibitors and glomerular filtration rate; SGLT2 inhibitors reduced albuminuria; Slow decline in glomerular filtration rate; Reduce albuminuria; Delay progression of CKD without diabetes; Value in prevention and treatment of diabetic kidney disease.

Download the factsheet to this webinar below or watch the on-demand video here: View the on-demand webinar



This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant

Boehringer Logo small 
Sponsorship information:
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant.
Topics covered:
Category: Webinars
Edition: Volume 1, Number 2, March-April 2021
Contributor(s): Cliff Bailey, Pam Brown

Article search and filter